Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
A 31-year-old woman with human immunodeficiency virus (HIV) and a history of pulmonary tuberculosis and oral herpes simplex presented with a 7-month history of hyperkeratotic plaques on the soles of her feet. The plaques were mildly tender on weight bearing but were otherwise asymptomatic. No change in size or number of lesions had occurred in the preceding several months. No history of widespread eruption or similar lesions elsewhere on the body could be elicited during the initial patient interview. The patient had discontinued her suppressive acyclovir therapy 2 months before her evaluation and was taking no other medications.
Physical examination revealed 7 discrete hyperkeratotic plaques involving the soles and lateral margins of both feet (Figure 1). The plaques were surrounded by a thin rim of erythema and covered with a light-brown friable crust. No nail dystrophy or subungual debris was present. The results of the remainder of the physical examination, which included the palms, were unremarkable.
Laboratory values were significant for leukopenia, mild anemia, and moderately elevated hepatic enzymes. The CD4 cell count was 0.08×109/L (80/µL). An initial mineral oil preparation revealed no organisms, and a potassium hydroxide preparation of skin scrapings was negative for fungal elements. Several punch biopsy specimens were obtained (Figure 2).
What is your diagnosis?
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.